{"id":68894,"date":"2021-06-11T05:42:17","date_gmt":"2021-06-11T10:42:17","guid":{"rendered":"https:\/\/milesfortis.com\/?p=68894"},"modified":"2021-06-11T07:46:39","modified_gmt":"2021-06-11T12:46:39","slug":"68894","status":"publish","type":"post","link":"https:\/\/milesfortis.com\/?p=68894","title":{"rendered":""},"content":{"rendered":"

Heart Inflammation in Young Men Higher Than Expected After Pfizer, Moderna Vaccines \u2014 U.S. CDC<\/a><\/p>\n

(Reuters) -A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer\/BioNTech and Moderna, according to data from two vaccine safety monitoring systems, the U.S. Centers for Disease Control and Prevention (CDC) said on Thursday.<\/p>\n

The CDC and other health regulators have been investigating heart inflammation cases after Israel\u2019s Health Ministry reported that it had found a likely link to the condition in young men who received Pfizer\u2019s COVID-19 vaccine.<\/p>\n

The agency said it is still assessing the risk from the condition and has not yet concluded that there was a causal relationship between the vaccines and cases of myocarditis or pericarditis.<\/p>\n

While some patients required hospitalization, most have fully recovered from their symptoms, the CDC said.<\/p>\n

<\/p>\n

More than half of the cases reported to the U.S. Vaccine Adverse Event Reporting System (VAERS) after people had received their second dose of either the Pfizer\/BioNTech or Moderna vaccines were in people between the ages of 12 and 24, the CDC said. Those age groups accounted for less than 9% of doses administered.<\/p>\n

“We clearly have an imbalance there,” Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, said in a presentation https:\/\/www.fda.gov\/media\/150054\/download to an advisory committee to the U.S. Food and Drug Administration meeting on Thursday.<\/p>\n

The overwhelming majority of the cases have occurred within a week of vaccination, Shimabukuro said.<\/p>\n

There were 283 observed cases of heart inflammation after the second vaccine dose in those aged 16 to 24 in the VAERS data. That compares with expectations of 10-to-102 cases for that age range based on U.S. population background incidence rates, the CDC said.<\/p>\n

Shimabukuro said there was a predominance of males in younger age groups among the reported heart inflammation cases.<\/p>\n

The median age of patients who experienced the inflammation after a second vaccine dose was 24, according to the VAERS data. Just under 80% of the cases were in men.<\/p>\n

Shimabukuro also said the Vaccine Safety Datalink (VSD) – another safety monitoring system – showed an increased incidence of heart inflammation in 16 to 39 year olds after their second shot when compared to the rate observed after the first dose.<\/p>\n

Pfizer said it supports the CDC’s assessment of the heart inflammation cases, noting that “the number of reports is small given the number of doses administered.”<\/p>\n

About 130 million people in the United States have received both doses of one of the mRNA vaccines.<\/p>\n

“It is important to understand that a careful assessment of the reports is ongoing and it has not been concluded that the mRNA COVID-19 vaccines cause myocarditis or pericarditis,” the company said in a statement.<\/p>\n

Moderna said it also has not established a causal association with the condition and its vaccine. It said it is actively working with public health and regulatory authorities to further assess the issue.<\/p>\n

The CDC said it will hold a meeting of its Advisory Committee on Immunization Practices next week to further evaluate the evidence and assess the risk of myocarditis following mRNA vaccination for COVID-19.<\/p>\n","protected":false},"excerpt":{"rendered":"

Heart Inflammation in Young Men Higher Than Expected After Pfizer, Moderna Vaccines \u2014 U.S. CDC (Reuters) -A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer\/BioNTech and Moderna, according to data from two vaccine safety monitoring systems, the U.S. Centers for Disease Control and … Continue reading “”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41],"tags":[],"class_list":["post-68894","post","type-post","status-publish","format-standard","hentry","category-health-medicine"],"_links":{"self":[{"href":"https:\/\/milesfortis.com\/index.php?rest_route=\/wp\/v2\/posts\/68894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/milesfortis.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/milesfortis.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/milesfortis.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/milesfortis.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=68894"}],"version-history":[{"count":2,"href":"https:\/\/milesfortis.com\/index.php?rest_route=\/wp\/v2\/posts\/68894\/revisions"}],"predecessor-version":[{"id":68905,"href":"https:\/\/milesfortis.com\/index.php?rest_route=\/wp\/v2\/posts\/68894\/revisions\/68905"}],"wp:attachment":[{"href":"https:\/\/milesfortis.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=68894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/milesfortis.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=68894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/milesfortis.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=68894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}